Viewing StudyNCT01822314



Ignite Creation Date: 2024-05-06 @ 1:31 AM
Last Modification Date: 2024-10-26 @ 11:05 AM
Study NCT ID: NCT01822314
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2013-03-25

Brief Title: Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
Sponsor: Fondazione Michelangelo
Organization: Fondazione Michelangelo

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
HER2 negative View
breast View
cancer View
unilateral View
non metastatic View